Rob Sahr on the Administration’s Aggressive Approach to Bayh-Dole Compliance
March-in Rights and Compulsory Licensing of Biopharmaceutical Inventions - Very few topics in international intellectual property have been as controversial as compulsory licensing. In the US, consumer groups have...more